BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 27865213)

  • 1. Phenotypic correction of Fanconi anemia cells in the murine bone marrow after carrier cell mediated delivery of lentiviral vector.
    Chakkaramakkil Verghese S; Goloviznina NA; Kurre P
    Stem Cell Res Ther; 2016 Nov; 7(1):170. PubMed ID: 27865213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional correction of fanconi anemia group C hematopoietic cells by the use of a novel lentiviral vector.
    Yamada K; Olsen JC; Patel M; Rao KW; Walsh CE
    Mol Ther; 2001 Apr; 3(4):485-90. PubMed ID: 11319908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in Gene Therapy for Fanconi Anemia.
    Río P; Navarro S; Bueren JA
    Hum Gene Ther; 2018 Oct; 29(10):1114-1123. PubMed ID: 30117331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene Therapy in Fanconi Anemia: A Matter of Time, Safety and Gene Transfer Tool Efficiency.
    Verhoeyen E; Roman-Rodriguez FJ; Cosset FL; Levy C; Rio P
    Curr Gene Ther; 2017; 16(5):297-308. PubMed ID: 28067165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stem Cell Genetic Therapy for Fanconi Anemia - A New Hope.
    Hanenberg H; Roellecke K; Wiek C
    Curr Gene Ther; 2017; 16(5):309-320. PubMed ID: 28067166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid lentiviral transduction preserves the engraftment potential of Fanca(-/-) hematopoietic stem cells.
    Müller LU; Milsom MD; Kim MO; Schambach A; Schuesler T; Williams DA
    Mol Ther; 2008 Jun; 16(6):1154-60. PubMed ID: 18398427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anchored Lentiviral Vector Episomes for Stem Cell Gene Therapy in Fanconi Anemia.
    Verghese SC; Kurre P
    Curr Gene Ther; 2017; 16(5):329-337. PubMed ID: 28093967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overnight transduction with foamyviral vectors restores the long-term repopulating activity of Fancc-/- stem cells.
    Si Y; Pulliam AC; Linka Y; Ciccone S; Leurs C; Yuan J; Eckermann O; Fruehauf S; Mooney S; Hanenberg H; Clapp DW
    Blood; 2008 Dec; 112(12):4458-65. PubMed ID: 18684868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engraftment and in vivo proliferation advantage of gene-corrected mobilized CD34
    Río P; Navarro S; Guenechea G; Sánchez-Domínguez R; Lamana ML; Yañez R; Casado JA; Mehta PA; Pujol MR; Surrallés J; Charrier S; Galy A; Segovia JC; Díaz de Heredia C; Sevilla J; Bueren JA
    Blood; 2017 Sep; 130(13):1535-1542. PubMed ID: 28801449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene therapy of Fanconi anemia: preclinical efficacy using lentiviral vectors.
    Galimi F; Noll M; Kanazawa Y; Lax T; Chen C; Grompe M; Verma IM
    Blood; 2002 Oct; 100(8):2732-6. PubMed ID: 12351379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engraftment of hematopoietic progenitor cells transduced with the Fanconi anemia group C gene (FANCC).
    Liu JM; Kim S; Read EJ; Futaki M; Dokal I; Carter CS; Leitman SF; Pensiero M; Young NS; Walsh CE
    Hum Gene Ther; 1999 Sep; 10(14):2337-46. PubMed ID: 10515453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retroviral mediated gene transfer of the Fanconi anemia complementation group C gene to hematopoietic progenitors of group C patients.
    Liu JM; Young NS; Walsh CE; Cottler-Fox M; Carter C; Dunbar C; Barrett AJ; Emmons R
    Hum Gene Ther; 1997 Sep; 8(14):1715-30. PubMed ID: 9322874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lentiviral-Mediated Gene Therapy in Fanconi Anemia-A Mice Reveals Long-Term Engraftment and Continuous Turnover of Corrected HSCs.
    Molina-Estevez FJ; Nowrouzi A; Lozano ML; Galy A; Charrier S; von Kalle C; Guenechea G; Bueren JA; Schmidt M
    Curr Gene Ther; 2015; 15(6):550-62. PubMed ID: 26415575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotype correction of Fanconi anemia group A hematopoietic stem cells using lentiviral vector.
    Yamada K; Ramezani A; Hawley RG; Ebell W; Arwert F; Arnold LW; Walsh CE
    Mol Ther; 2003 Oct; 8(4):600-10. PubMed ID: 14529833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical correction of human Fanconi anemia complementation group A bone marrow cells using a safety-modified lentiviral vector.
    Becker PS; Taylor JA; Trobridge GD; Zhao X; Beard BC; Chien S; Adair J; Kohn DB; Wagner JE; Shimamura A; Kiem HP
    Gene Ther; 2010 Oct; 17(10):1244-52. PubMed ID: 20485382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimal conditioning in Fanconi anemia promotes multi-lineage marrow engraftment at 10-fold lower cell doses.
    Haworth KG; Ironside C; Ramirez MA; Weitz S; Beard BC; Schwartz JD; Adair JE; Kiem HP
    J Gene Med; 2018 Oct; 20(10-11):e3050. PubMed ID: 30129972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector.
    Walsh CE; Nienhuis AW; Samulski RJ; Brown MG; Miller JL; Young NS; Liu JM
    J Clin Invest; 1994 Oct; 94(4):1440-8. PubMed ID: 7929819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic correction of Fanconi anemia group C knockout mice.
    Gush KA; Fu KL; Grompe M; Walsh CE
    Blood; 2000 Jan; 95(2):700-4. PubMed ID: 10627482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro phenotypic correction of hematopoietic progenitors from Fanconi anemia group A knockout mice.
    Río P; Segovia JC; Hanenberg H; Casado JA; Martínez J; Göttsche K; Cheng NC; Van de Vrugt HJ; Arwert F; Joenje H; Bueren JA
    Blood; 2002 Sep; 100(6):2032-9. PubMed ID: 12200363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lessons Learned from Two Decades of Clinical Trial Experience in Gene Therapy for Fanconi Anemia.
    Adair JE; Sevilla J; Heredia CD; Becker PS; Kiem HP; Bueren J
    Curr Gene Ther; 2017; 16(5):338-348. PubMed ID: 28103787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.